Kinetic analysis of the polymerization and depolymerization of beta(2)-microglobulin-related amyloid fibrils in vitro.

[1]  Zhanjiang Li,et al.  Novel glycosaminoglycan precursors as anti-amyloid agents, Part III , 2002, Journal of Molecular Neuroscience.

[2]  Suguru Yamamoto,et al.  Low concentrations of sodium dodecyl sulfate induce the extension of beta 2-microglobulin-related amyloid fibrils at a neutral pH. , 2004, Biochemistry.

[3]  F. Gejyo,et al.  Glycosaminoglycans enhance the trifluoroethanol-induced extension of beta 2-microglobulin-related amyloid fibrils at a neutral pH. , 2004, Journal of the American Society of Nephrology : JASN.

[4]  K. Ohashi,et al.  Proteoglycans in haemodialysis-related amyloidosis , 2004, Virchows Archiv.

[5]  F. Gejyo,et al.  Glycosaminoglycan and proteoglycan inhibit the depolymerization of beta2-microglobulin amyloid fibrils in vitro. , 2003, Kidney international.

[6]  J. Torres,et al.  Conformational Switching and Fibrillogenesis in the Amyloidogenic Fragment of Apolipoprotein A-I* , 2003, The Journal of Biological Chemistry.

[7]  J. Ancsin.  Amyloidogenesis: historical and modern observations point to heparan sulfate proteoglycans as a major culprit , 2003, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[8]  C. Dobson,et al.  Stimulation and inhibition of fibril formation by a peptide in the presence of different concentrations of SDS , 2002, FEBS letters.

[9]  D. Teplow,et al.  Kinetic Studies of Amyloid β-Protein Fibril Assembly , 2002, The Journal of Biological Chemistry.

[10]  Sofia Nyström,et al.  Transmissibility of systemic amyloidosis by a prion-like mechanism , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[11]  M. Hoshino,et al.  Mapping the core of the β2-microglobulin amyloid fibril by H/D exchange , 2002, Nature Structural Biology.

[12]  S. Ji,et al.  Cholesterol Is an Important Factor Affecting the Membrane Insertion of β-Amyloid Peptide (Aβ1–40), Which May Potentially Inhibit the Fibril Formation* , 2002, The Journal of Biological Chemistry.

[13]  K. Ohashi,et al.  Affinity Binding of Glycosaminoglycans with β2-Microglobulin , 2002, Nephron.

[14]  M. Hoshino,et al.  Aggregation of beta(2)-glycoprotein I induced by sodium lauryl sulfate and lysophospholipids. , 2002, Biochemistry.

[15]  C. Dobson,et al.  A Partially Structured Species of β2-Microglobulin Is Significantly Populated under Physiological Conditions and Involved in Fibrillogenesis* , 2001, The Journal of Biological Chemistry.

[16]  D A Smith,et al.  Beta(2)-microglobulin and its deamidated variant, N17D form amyloid fibrils with a range of morphologies in vitro. , 2001, Journal of molecular biology.

[17]  N. Heegaard,et al.  Conformational Intermediate of the Amyloidogenic Protein β2-Microglobulin at Neutral pH* , 2001, The Journal of Biological Chemistry.

[18]  F. Gejyo,et al.  Apolipoprotein E inhibits the depolymerization of beta 2-microglobulin-related amyloid fibrils at a neutral pH. , 2001, Biochemistry.

[19]  Y. Kozutsumi,et al.  Cholesterol-dependent Formation of GM1 Ganglioside-bound Amyloid β-Protein, an Endogenous Seed for Alzheimer Amyloid* , 2001, The Journal of Biological Chemistry.

[20]  C. Dobson,et al.  Detection of two partially structured species in the folding process of the amyloidogenic protein beta 2-microglobulin. , 2001, Journal of molecular biology.

[21]  P. Fraser,et al.  Amyloid-beta interactions with chondroitin sulfate-derived monosaccharides and disaccharides. implications for drug development. , 2001, The Journal of biological chemistry.

[22]  D. Heinegård,et al.  Age-related changes in the synthesis and mRNA expression of decorin and aggrecan in human meniscus and articular cartilage. , 2001, Osteoarthritis and cartilage.

[23]  T. Chiba,et al.  Transmission of Mouse Senile Amyloidosis , 2001, Laboratory Investigation.

[24]  P. Fraser,et al.  Effect of amino-acid substitutions on Alzheimer's amyloid-beta peptide-glycosaminoglycan interactions. , 2000, European journal of biochemistry.

[25]  A. Koide,et al.  Solution conformation and amyloid-like fibril formation of a polar peptide derived from a beta-hairpin in the OspA single-layer beta-sheet. , 2000, Journal of molecular biology.

[26]  A. Fagan,et al.  Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. Dobson,et al.  Evidence concerning rate-limiting steps in protein folding from the effects of trifluoroethanol , 2000, Nature Structural Biology.

[28]  W. Surewicz,et al.  Membrane Environment Alters the Conformational Structure of the Recombinant Human Prion Protein* , 1999, The Journal of Biological Chemistry.

[29]  S. Paul,et al.  Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[30]  P. Fraser,et al.  Interactions of Alzheimer amyloid-beta peptides with glycosaminoglycans effects on fibril nucleation and growth. , 1999, European journal of biochemistry.

[31]  P. Roughley,et al.  Age-related changes in fibromodulin and lumican in human intervertebral discs. , 1999, Spine.

[32]  M. Jadoul,et al.  Histological characteristics of sternoclavicular beta 2-microglobulin amyloidosis and clues for its histogenesis. , 1999, Kidney international.

[33]  R. Kisilevsky,et al.  The Heparin/Heparan Sulfate-binding Site on Apo-serum Amyloid A , 1999, The Journal of Biological Chemistry.

[34]  H. Shao,et al.  Solution structures of micelle-bound amyloid beta-(1-40) and beta-(1-42) peptides of Alzheimer's disease. , 1999, Journal of molecular biology.

[35]  F. Gejyo,et al.  Apolipoprotein E and antioxidants have different mechanisms of inhibiting Alzheimer's beta-amyloid fibril formation in vitro. , 1998, Biochemistry.

[36]  M. Okita,et al.  The significance of plasma lysophospholipids in patients with renal failure on hemodialysis. , 1998, Journal of nutritional science and vitaminology.

[37]  M. Jadoul,et al.  Prevalence of histological beta2-microglobulin amyloidosis in CAPD patients compared with hemodialysis patients. , 1998, Kidney international.

[38]  M. Buck,et al.  Trifluoroethanol and colleagues: cosolvents come of age. Recent studies with peptides and proteins , 1998, Quarterly Reviews of Biophysics.

[39]  R. Iozzo.  Matrix proteoglycans: from molecular design to cellular function. , 1998, Annual review of biochemistry.

[40]  D. Rader,et al.  Reduction in amyloid A amyloid formation in apolipoprotein-E-deficient mice. , 1998, The American journal of pathology.

[41]  M. Judge,et al.  Sulfate content and specific glycosaminoglycan backbone of perlecan are critical for perlecan's enhancement of islet amyloid polypeptide (amylin) fibril formation. , 1998, Diabetes.

[42]  T. Wight,et al.  Perlecan Binds to the β‐Amyloid Proteins (Aβ) of Alzheimer's Disease, Accelerates Aβ Fibril Formation, and Maintains Aβ Fibril Stability , 1997 .

[43]  K. Ohashi,et al.  Ultrastructural organization of hemodialysis-associated beta 2-microglobulin amyloid fibrils. , 1997, Kidney international.

[44]  S. K. Lim,et al.  Serum amyloid P component enhances induction of murine amyloidosis. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[45]  D. Cui,et al.  Amyloid A protein amyloidosis induced in apolipoprotein-E-deficient mice. , 1997, The American journal of pathology.

[46]  George B. Benedek,et al.  Kinetic theory of fibrillogenesis of amyloid β-protein , 1997 .

[47]  À. Argilés,et al.  Monomeric and dimeric beta 2-microglobulin may be extracted from amyloid deposits in vitro. , 1997, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[48]  K. Ohashi,et al.  Visceral organ involvement and extracellular matrix changes in β2-microglobulin amyloidosis – a comparative study with systemic AA and AL amyloidosis , 1997, Virchows Archiv.

[49]  F. Gejyo,et al.  Concentration-dependent inhibitory effects of apolipoprotein E on Alzheimer's beta-amyloid fibril formation in vitro. , 1997, Biochemistry.

[50]  Satoru Suzuki,et al.  Establishment of a kinetic model of dialysis-related amyloid fibril extension in vitro , 1997 .

[51]  Increased risk of dialysis-related amyloidosis in patients with the apolipoprotein E4 allele , 1997 .

[52]  R. Iozzo,et al.  The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. , 1997, Critical reviews in biochemistry and molecular biology.

[53]  M. Skinner,et al.  Polymerization of normal and intact beta 2-microglobulin as the amyloidogenic protein in dialysis-amyloidosis. , 1996, Kidney international.

[54]  F. Gejyo,et al.  High prevalence of serum apolipoprotein E4 isoprotein in rheumatoid arthritis patients with amyloidosis. , 1996, Arthritis and rheumatism.

[55]  R. Wetzel,et al.  Seeding of A beta fibril formation is inhibited by all three isotypes of apolipoprotein E. , 1996, Biochemistry.

[56]  R. Strugnell,et al.  Eukaryotic Expression of Recombinant Biglycan , 1996, The Journal of Biological Chemistry.

[57]  M. Pepys,et al.  Long term effect of renal transplantation on dialysis-related amyloid deposits and symptomatology. , 1996, Kidney international.

[58]  Thomas Wisniewski,et al.  The Interaction between Apolipoprotein E and Alzheimers Amyloid -Peptide Is Dependent on -Peptide Conformation (*) , 1996, The Journal of Biological Chemistry.

[59]  H. Naiki,et al.  First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[60]  J. Kelly,et al.  Alternative conformations of amyloidogenic proteins govern their behavior. , 1996, Current opinion in structural biology.

[61]  M. Kindy,et al.  Association of apolipoprotein E with murine amyloid A protein amyloid. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[62]  Y. Ihara,et al.  GM1 ganglioside–bound amyloid β–protein (Aβ): A possible form of preamyloid in Alzheimer's disease , 1995, Nature Medicine.

[63]  J. Laredo,et al.  Dialysis arthropathy: outcome after renal transplantation. , 1995, The American journal of medicine.

[64]  K. Brunden,et al.  Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation. , 1995, The Journal of biological chemistry.

[65]  M. Pras,et al.  Apolipoprotein E Carboxyl-terminal Fragments Are Complexed to Amyloids A and L , 1995, The Journal of Biological Chemistry.

[66]  L. Lovat,et al.  Serum amyloid P component prevents proteolysis of the amyloid fibrils of Alzheimer disease and systemic amyloidosis. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[67]  T. Wisniewski,et al.  Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. , 1995, The Biochemical journal.

[68]  H Kresse,et al.  Interaction of Biglycan with Type I Collagen (*) , 1995, The Journal of Biological Chemistry.

[69]  P. Fraser,et al.  Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer's disease , 1995, Nature Medicine.

[70]  P. Lansbury,et al.  Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[71]  K. Nishikawa,et al.  Trifluoroethanol-induced Stabilization of the α-Helical Structure of β-Lactoglobulin: Implication for Non-hierarchical Protein Folding , 1995 .

[72]  A. Davison.  beta 2-microglobulin and amyloidosis: who is at risk? , 1995, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[73]  H. Brewer,et al.  Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments , 1994, Nature.

[74]  T Vogel,et al.  Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. , 1994, The American journal of pathology.

[75]  G Pogány,et al.  The in vitro interaction of proteoglycans with type I collagen is modulated by phosphate. , 1994, Archives of biochemistry and biophysics.

[76]  A. Roses,et al.  Apolipoprotein E associates with beta amyloid peptide of Alzheimer's disease to form novel monofibrils. Isoform apoE4 associates more efficiently than apoE3. , 1994, The Journal of clinical investigation.

[77]  F. Gejyo,et al.  A monoclonal antibody recognizing apolipoprotein E peptides in systemic amyloid deposits. , 1994, Annals of clinical and laboratory science.

[78]  P. Roughley,et al.  Changes in the expression of decorin and biglycan in human articular cartilage with age and regulation by TGF-beta. , 1994, Matrix biology : journal of the International Society for Matrix Biology.

[79]  P. Roughley,et al.  Non-proteoglycan forms of biglycan increase with age in human articular cartilage. , 1993, The Biochemical journal.

[80]  P. Lansbury,et al.  Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.

[81]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[82]  J. Volanakis,et al.  The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex. , 1992, Journal of immunology.

[83]  M. Skinner,et al.  Demonstration of plasma proteinase inhibitors in beta 2-microglobulin amyloid deposits. , 1992, Kidney international.

[84]  M. Solé,et al.  In vitro spontaneous synthesis of beta 2-microglobulin amyloid fibrils in peripheral blood mononuclear cell culture. , 1992, The American journal of pathology.

[85]  K. Ohashi,et al.  Cervical discs are most susceptible to beta 2-microglobulin amyloid deposition in the vertebral column. , 1992, Kidney international.

[86]  K. Koch,et al.  Dialysis-related amyloidosis. , 1992, Kidney international.

[87]  Thomas Wisniewski,et al.  Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid , 1992, Neuroscience Letters.

[88]  T. Hardingham,et al.  Proteoglycans: many forms and many functions , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[89]  F. Oppenheimer,et al.  Renal transplantation for dialysis amyloidosis. , 1992, Transplantation proceedings.

[90]  R. Bramson,et al.  A temporal and ultrastructural relationship between heparan sulfate proteoglycans and AA amyloid in experimental amyloidosis. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[91]  M. Pepys,et al.  Imaging of haemodialysis-associated amyloidosis with 123I-serum amyloid P component , 1991, The Lancet.

[92]  K. Higuchi,et al.  Kinetic analysis of amyloid fibril polymerization in vitro. , 1991, Laboratory investigation; a journal of technical methods and pathology.

[93]  B. Maldague,et al.  Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. The Working Party on Dialysis Amyloidosis. , 1991, Kidney international.

[94]  E. Otomo,et al.  Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease , 1991, Brain Research.

[95]  E. Ruoslahti,et al.  Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.

[96]  F. Gejyo,et al.  Dialysis amyloidosis: current disease concepts and new perspectives for its treatment. , 1990, Contributions to nephrology.

[97]  M. Skinner,et al.  Glycosaminoglycans of the hemodialysis-associated carpal synovial amyloid and of amyloid-rich tissues and fibrils of heart, liver, and spleen. , 1990, Clinical chemistry.

[98]  B. Maldague,et al.  Effect of renal transplantation on the radiological signs of dialysis amyloid osteoarthropathy. , 1989, Clinical nephrology.

[99]  O. Toupance,et al.  Carpal tunnel syndrome and type of dialysis membrane. , 1989, BMJ.

[100]  C. Kay,et al.  Circular-dichroism studies on two murine serum amyloid A proteins. , 1988, The Biochemical journal.

[101]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[102]  N. Tuross,et al.  Purification and partial characterization of small proteoglycans I and II, bone sialoproteins I and II, and osteonectin from the mineral compartment of developing human bone. , 1987, The Journal of biological chemistry.

[103]  B. Frangione,et al.  Polymerization of intact beta 2-microglobulin in tissue causes amyloidosis in patients on chronic hemodialysis. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[104]  F. Gejyo,et al.  Serum levels of beta 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis. , 1986, The New England journal of medicine.

[105]  M Arakawa,et al.  A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. , 1985, Biochemical and biophysical research communications.

[106]  L. Tang,et al.  Isolation of dermatan sulfate proteoglycans from mature bovine articular cartilages. , 1985, The Journal of biological chemistry.

[107]  B. Charra,et al.  Carpal tunnel syndrome, shoulder pain and amyloid deposits in long-term haemodialysis patients. , 1985, Proceedings of the European Dialysis and Transplant Association - European Renal Association. European Dialysis and Transplant Association - European Renal Association. Congress.

[108]  B Honig,et al.  Crystallographic studies of protein denaturation and renaturation. 2. Sodium dodecyl sulfate induced structural changes in triclinic lysozyme. , 1977, Biochemistry.

[109]  W. Mattice,et al.  Conformational properties of the complexes formed by proteins and sodium dodecyl sulfate. , 1976, Biochemistry.

[110]  C. Tanford,et al.  The gross conformation of protein-sodium dodecyl sulfate complexes. , 1970, The Journal of biological chemistry.

[111]  B. Jirgensons.  Effects of n-propyl alcohol and detergents on the optical rotatory dispersion of alpha-chymotrypsinogen, beta-casein, histone fraction F1, and soybean trypsin inhibitor. , 1967, The Journal of biological chemistry.